Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Ligand to Supply Captisol to Merck

By Pharmaceutical Processing | June 20, 2011

 

Ligand Pharmaceuticals Incorporated has entered into a Captisol(R)
supply agreement with Merck & Co., Inc. for an undisclosed program. Ligand
will supply clinical and commercial supplies of Captisol and, if the program is
approved for commercialization, expects to deliver multiple metric tons of
Captisol annually. Financial terms of the deal were not disclosed.

“We are extremely pleased to enter into a long-term commercial
supply agreement for this Captisol-enabled program,” said Matt Foehr, Executive
Vice President and Chief Operating Officer of Ligand Pharmaceuticals.
“This collaboration with Merck is a good example of the type of
relationships we try to build with our partners. Merck used Captisol to
reformulate a drug in their portfolio and performed initial proof of concept
under a research use agreement.” “This announcement marks the natural
transition of the program to a full commercial supply relationship as commercialization
approaches,” added Mr. Foehr. “This deal has the potential to add
meaningful revenue to the Ligand business in the coming years and extends the already
significant partnering relationship that we have developed with Merck over the
past few years.”   

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE